Drugs / Nanoplatin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00910741 | May 2009 → Jul 2013 | — | NanoCarrier Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nanoplatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00910741 ↗ |
| Known as | NC-6004 | “Nanoplatin (NC-6004) and Gemcitabine” NCT00910741 ↗ |